{
  "title": "Patient-Reported Symptom Assessment and Early Chemotherapy Discontinuation in ... - medRxiv",
  "url": "https://www.medrxiv.org/content/10.1101/2025.10.07.25337194v1",
  "summary": [
    {
      "type": "bullet",
      "text": "The study highlights that completing more frequent patient-reported symptom assessments after gastrointestinal cancer treatment initiation is associated with a lower risk of early discontinuation due to toxicity."
    },
    {
      "type": "bullet",
      "text": "This association was consistent across different prognostic groups, suggesting its relevance in various stages and types of GI cancers."
    },
    {
      "type": "bullet",
      "text": "The findings underscore the importance of regular symptom monitoring as a tool for improving adherence to chemotherapy regimens and potentially enhancing patient outcomes."
    }
  ],
  "model": "granite4:tiny-h"
}